EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.
<h4>Background</h4>Gain-of-function of erythropoietin receptor (EPOR) mutations represent the major cause of primary hereditary polycythemia. EPOR is also found in non-erythroid tissues, although its physiological role is still undefined.<h4>Methodology/principal findings</h4>...
Guardado en:
Autores principales: | Silverio Perrotta, Valeria Cucciolla, Marcella Ferraro, Luisa Ronzoni, Annunziata Tramontano, Francesca Rossi, Anna Chiara Scudieri, Adriana Borriello, Domenico Roberti, Bruno Nobili, Maria Domenica Cappellini, Adriana Oliva, Giovanni Amendola, Anna Rita Migliaccio, Patrizia Mancuso, Ines Martin-Padura, Francesco Bertolini, Donghoon Yoon, Josef T Prchal, Fulvio Della Ragione |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c749460bfd1e4e51998c1c626fd9cba6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The tyrosine kinase inhibitor dasatinib induces a marked adipogenic differentiation of human multipotent mesenchymal stromal cells.
por: Adriana Borriello, et al.
Publicado: (2011) - Epos
-
CONCOMITANT LATENT POLYCYTHEMIA VERA AND MGUS.
por: Fidan KHALILOVA, et al.
Publicado: (2021) -
Polycythemia Vera (PV): Update on Emerging Treatment Options
por: Benevolo G, et al.
Publicado: (2021) -
Hereditary hemochromatosis and JAK2‐positive polycythemia vera
por: Ahmed Radwan, et al.
Publicado: (2021)